| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-07 23:02:45 UTC |
|---|
| Updated at | 2022-09-07 23:02:45 UTC |
|---|
| NP-MRD ID | NP0257812 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (7s,8s)-11-hydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one |
|---|
| Description | Tilivalline belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. Tilivalline is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. (7s,8s)-11-hydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one was first documented in 2017 (PMID: 28972161). Based on a literature review a significant number of articles have been published on tilivalline (PMID: 28993611) (PMID: 29596433) (PMID: 35073747) (PMID: 34851134) (PMID: 34659176) (PMID: 34582979). |
|---|
| Structure | OC1=C2N[C@H]([C@@H]3CCCN3C(=O)C2=CC=C1)C1=CNC2=CC=CC=C12 InChI=1S/C20H19N3O2/c24-17-9-3-6-13-19(17)22-18(16-8-4-10-23(16)20(13)25)14-11-21-15-7-2-1-5-12(14)15/h1-3,5-7,9,11,16,18,21-22,24H,4,8,10H2/t16-,18-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (7S,8S)-11-Hydroxy-8-(1H-indol-3-yl)-3,9-diazatricyclo[8.4.0.0(3,7)]tetradeca-1(10),11,13-trien-2-one | ChEBI | | Epitilivalline | ChEBI |
|
|---|
| Chemical Formula | C20H19N3O2 |
|---|
| Average Mass | 333.3910 Da |
|---|
| Monoisotopic Mass | 333.14773 Da |
|---|
| IUPAC Name | (7S,8S)-11-hydroxy-8-(1H-indol-3-yl)-3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),11,13-trien-2-one |
|---|
| Traditional Name | (7S,8S)-11-hydroxy-8-(1H-indol-3-yl)-3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),11,13-trien-2-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC1=C2N[C@H]([C@@H]3CCCN3C(=O)C2=CC=C1)C1=CNC2=CC=CC=C12 |
|---|
| InChI Identifier | InChI=1S/C20H19N3O2/c24-17-9-3-6-13-19(17)22-18(16-8-4-10-23(16)20(13)25)14-11-21-15-7-2-1-5-12(14)15/h1-3,5-7,9,11,16,18,21-22,24H,4,8,10H2/t16-,18-/m0/s1 |
|---|
| InChI Key | AJZNARCWDDMOPL-WMZOPIPTSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzodiazepines |
|---|
| Sub Class | 1,4-benzodiazepines |
|---|
| Direct Parent | 1,4-benzodiazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,4-benzodiazepine
- 3-alkylindole
- Indole
- Indole or derivatives
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Secondary aliphatic/aromatic amine
- Aralkylamine
- Substituted pyrrole
- Benzenoid
- Pyrrole
- Pyrrolidine
- Tertiary carboxylic acid amide
- Heteroaromatic compound
- Vinylogous amide
- Amino acid or derivatives
- Lactam
- Carboxamide group
- Secondary amine
- Carboxylic acid derivative
- Azacycle
- Organic oxide
- Organopnictogen compound
- Amine
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Tse H, Gu Q, Sze KH, Chu IK, Kao RY, Lee KC, Lam CW, Yang D, Tai SS, Ke Y, Chan E, Chan WM, Dai J, Leung SP, Leung SY, Yuen KY: A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis. J Biol Chem. 2017 Nov 24;292(47):19503-19520. doi: 10.1074/jbc.M117.791558. Epub 2017 Sep 26. [PubMed:28972161 ]
- Tobias NJ, Wolff H, Djahanschiri B, Grundmann F, Kronenwerth M, Shi YM, Simonyi S, Grun P, Shapiro-Ilan D, Pidot SJ, Stinear TP, Ebersberger I, Bode HB: Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus. Nat Microbiol. 2017 Dec;2(12):1676-1685. doi: 10.1038/s41564-017-0039-9. Epub 2017 Oct 9. [PubMed:28993611 ]
- Wolff H, Bode HB: The benzodiazepine-like natural product tilivalline is produced by the entomopathogenic bacterium Xenorhabdus eapokensis. PLoS One. 2018 Mar 29;13(3):e0194297. doi: 10.1371/journal.pone.0194297. eCollection 2018. [PubMed:29596433 ]
- Ledala N, Malik M, Rezaul K, Paveglio S, Provatas A, Kiel A, Caimano M, Zhou Y, Lindgren J, Krasulova K, Illes P, Dvorak Z, Kortagere S, Kienesberger S, Cosic A, Poltl L, Zechner EL, Ghosh S, Mani S, Radolf JD, Matson AP: Bacterial Indole as a Multifunctional Regulator of Klebsiella oxytoca Complex Enterotoxicity. mBio. 2022 Feb 22;13(1):e0375221. doi: 10.1128/mbio.03752-21. Epub 2022 Jan 25. [PubMed:35073747 ]
- Yang J, Long H, Hu Y, Feng Y, McNally A, Zong Z: Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence. Clin Microbiol Rev. 2022 Jan 19;35(1):e0000621. doi: 10.1128/CMR.00006-21. Epub 2021 Dec 1. [PubMed:34851134 ]
- Rodriguez-Valverde D, Leon-Montes N, Soria-Bustos J, Martinez-Cruz J, Gonzalez-Ugalde R, Rivera-Gutierrez S, Gonzalez-Y-Merchand JA, Rosales-Reyes R, Garcia-Morales L, Hirakawa H, Fox JG, Giron JA, De la Cruz MA, Ares MA: cAMP Receptor Protein Positively Regulates the Expression of Genes Involved in the Biosynthesis of Klebsiella oxytoca Tilivalline Cytotoxin. Front Microbiol. 2021 Sep 30;12:743594. doi: 10.3389/fmicb.2021.743594. eCollection 2021. [PubMed:34659176 ]
- Leitner E, Bozic M, Kienesberger S, Cosic A, Landt O, Hogenauer C, Kessler HH: Improved diagnosis of antibiotic-associated haemorrhagic colitis (AAHC) in faecal specimens by a new qualitative real-time PCR assay detecting relevant toxin genes of Klebsiella oxytoca sensu lato. Clin Microbiol Infect. 2022 May;28(5):690-694. doi: 10.1016/j.cmi.2021.09.017. Epub 2021 Sep 25. [PubMed:34582979 ]
- Greimel TM, Stampfer L, Leitner E, Kienesberger S, Zechner EL, Bozic M, Wagner GE, Unterhauser K, Kitsera M, Hauer AC, Gorkiewicz G, Wurm P, Valitutti F, Hogenauer C, Hoffmann KM: Toxin-Producing Klebsiella oxytoca in Healthy Infants: Commensal or Pathobiont? J Pediatr Gastroenterol Nutr. 2022 Jan 1;74(1):e1-e7. doi: 10.1097/MPG.0000000000003299. [PubMed:34520403 ]
- Neog N, Phukan U, Puzari M, Sharma M, Chetia P: Klebsiella oxytoca and Emerging Nosocomial Infections. Curr Microbiol. 2021 Apr;78(4):1115-1123. doi: 10.1007/s00284-021-02402-2. Epub 2021 Mar 3. [PubMed:33656584 ]
- Glabonjat RA, Kitsera M, Unterhauser K, Lembacher-Fadum C, Hogenauer C, Raber G, Breinbauer R, Zechner EL: Simultaneous quantification of enterotoxins tilimycin and tilivalline in biological matrices using HPLC high resolution ESMS(2) based on isotopically (15)N-labeled internal standards. Talanta. 2021 Jan 15;222:121677. doi: 10.1016/j.talanta.2020.121677. Epub 2020 Sep 17. [PubMed:33167283 ]
- Hering NA, Fromm A, Bucker R, Gorkiewicz G, Zechner E, Hogenauer C, Fromm M, Schulzke JD, Troeger H: Tilivalline- and Tilimycin-Independent Effects of Klebsiella oxytoca on Tight Junction-Mediated Intestinal Barrier Impairment. Int J Mol Sci. 2019 Nov 8;20(22):5595. doi: 10.3390/ijms20225595. [PubMed:31717457 ]
- Unterhauser K, Poltl L, Schneditz G, Kienesberger S, Glabonjat RA, Kitsera M, Pletz J, Josa-Prado F, Dornisch E, Lembacher-Fadum C, Roier S, Gorkiewicz G, Lucena D, Barasoain I, Kroutil W, Wiedner M, Loizou JI, Breinbauer R, Diaz JF, Schild S, Hogenauer C, Zechner EL: Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3774-3783. doi: 10.1073/pnas.1819154116. Epub 2019 Feb 11. [PubMed:30808763 ]
- Pavlikova M, Kamenik Z, Janata J, Kadlcik S, Kuzma M, Najmanova L: Novel pathway of 3-hydroxyanthranilic acid formation in limazepine biosynthesis reveals evolutionary relation between phenazines and pyrrolobenzodiazepines. Sci Rep. 2018 May 17;8(1):7810. doi: 10.1038/s41598-018-26179-w. [PubMed:29773836 ]
- von Tesmar A, Hoffmann M, Abou Fayad A, Huttel S, Schmitt V, Herrmann J, Muller R: Biosynthesis of the Klebsiella oxytoca Pathogenicity Factor Tilivalline: Heterologous Expression, in Vitro Biosynthesis, and Inhibitor Development. ACS Chem Biol. 2018 Mar 16;13(3):812-819. doi: 10.1021/acschembio.7b00990. Epub 2018 Feb 13. [PubMed:29389112 ]
- Dornisch E, Pletz J, Glabonjat RA, Martin F, Lembacher-Fadum C, Neger M, Hogenauer C, Francesconi K, Kroutil W, Zangger K, Breinbauer R, Zechner EL: Biosynthesis of the Enterotoxic Pyrrolobenzodiazepine Natural Product Tilivalline. Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14753-14757. doi: 10.1002/anie.201707737. Epub 2017 Oct 18. [PubMed:28977734 ]
- LOTUS database [Link]
|
|---|